Literature DB >> 16874813

Crossed polydactyly type I caused by a point mutation in the GLI3 gene in a large Chinese pedigree.

Baowen Cheng1, Yongli Dong, Li He, Wenru Tang, Haijing Yu, Jing Lu, Lin Xu, Bingrong Zheng, Kaiyuan Li, Chunjie Xiao.   

Abstract

Polydactyly is one of the most common forms of congenital malformation in humans, and is displayed by 119 disorders. Crossed polydactyly (CP) is defined as the coexistence of preaxial and postaxial polydactyly with a difference in the axes of polydactyly between the hands and feet. In an effort to map the gene responsible for CP, we studied a seven-generation Chinese family of 56 individuals, 28 of whom were affected. A thorough search with highly informative polymorphic markers showed no recombination among the affected members with the markers on chromosome 7p15-q11.23, but no linkage with chromosomes 2q31, 7q36, 13q, and 19p. Mutation analysis showed a substitution mutation of 1927C --> T in exon 12 of the GLI3 gene, which is predicted to pretruncate the GLI3 protein. This mutation has variable phenotypes of polydactyly, indicating that other genetic factors also contribute to the diversity of polydactyly phenotypes. Our results increase the phenotypic spectrum caused by GLI3 mutations and are important for the analysis and understanding of the etiology of these limb malformations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16874813      PMCID: PMC6807395          DOI: 10.1002/jcla.20121

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  19 in total

Review 1.  Polydactyly: how many disorders and how many genes?

Authors:  Leslie G Biesecker
Journal:  Am J Med Genet       Date:  2002-10-15

2.  Sending and receiving the hedgehog signal: control by the Drosophila Gli protein Cubitus interruptus.

Authors:  M Domínguez; M Brunner; E Hafen; K Basler
Journal:  Science       Date:  1996-06-14       Impact factor: 47.728

3.  Crossed polydactyly type I in a mother and son: an autosomal dominant trait?

Authors:  S Ishikiriyama; H Sawada; H Nambu; N Niikawa
Journal:  Am J Med Genet       Date:  1991-07-01

4.  Isolation of high-molecular-weight DNA from mammalian cells.

Authors:  M Gross-Bellard; P Oudet; P Chambon
Journal:  Eur J Biochem       Date:  1973-07-02

5.  The phenotypic spectrum of GLI3 morphopathies includes autosomal dominant preaxial polydactyly type-IV and postaxial polydactyly type-A/B; No phenotype prediction from the position of GLI3 mutations.

Authors:  U Radhakrishna; D Bornholdt; H S Scott; U C Patel; C Rossier; H Engel; A Bottani; D Chandal; J L Blouin; J V Solanki; K H Grzeschik; S E Antonarakis
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

6.  Gene structure and allelic expression assay of the human GLI3 gene.

Authors:  S Kang; M Rosenberg; V D Ko; L G Biesecker
Journal:  Hum Genet       Date:  1997-12       Impact factor: 4.132

7.  Strategies for multilocus linkage analysis in humans.

Authors:  G M Lathrop; J M Lalouel; C Julier; J Ott
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

8.  Localization of the syndactyly type II (synpolydactyly) locus to 2q31 region and identification of tight linkage to HOXD8 intragenic marker.

Authors:  M Sarfarazi; A N Akarsu; B S Sayli
Journal:  Hum Mol Genet       Date:  1995-08       Impact factor: 6.150

9.  Progression of vertebrate limb development through SHH-mediated counteraction of GLI3.

Authors:  Pascal te Welscher; Aimée Zuniga; Sanne Kuijper; Thijs Drenth; Hans J Goedemans; Frits Meijlink; Rolf Zeller
Journal:  Science       Date:  2002-09-05       Impact factor: 47.728

10.  Shh and Gli3 are dispensable for limb skeleton formation but regulate digit number and identity.

Authors:  Ying Litingtung; Randall D Dahn; Yina Li; John F Fallon; Chin Chiang
Journal:  Nature       Date:  2002-08-18       Impact factor: 49.962

View more
  2 in total

1.  Drug exposure and pregnancy outcome in Mozambique.

Authors:  Esperança Sevene; Azucena Bardají; Alda Mariano; Sónia Machevo; Edgar Ayala; Betuel Sigaúque; John J Aponte; Xavier Carné; Pedro L Alonso; Clara Menendez
Journal:  Paediatr Drugs       Date:  2012-02-01       Impact factor: 3.022

2.  Safety of artemether-lumefantrine exposure in first trimester of pregnancy: an observational cohort.

Authors:  Dominic Mosha; Festo Mazuguni; Sigilbert Mrema; Esperanca Sevene; Salim Abdulla; Blaise Genton
Journal:  Malar J       Date:  2014-05-27       Impact factor: 2.979

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.